Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T cell therapy in real time. The organoid's response to ...
Patient-derived glioblastoma organoid treated with dual-target CAR-T cells. T cells (magenta) infiltrate the tumor organoid and kill tumor cells (blue) (yellow indicates dying cells). PHILADELPHIA— ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback